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Abstract
Backround/Aim. Retraction agents for temporary vertical
and lateral suppression of gingival tissue as well as bleeding
control and fluid flow in the gingival sulcus are expected to
have maximal efficiency without irreversible damage of local
tissue and adverse systemic effects. The research started
from the assumption that tetrahydrozoline is a biologically
more acceptable means of gingival retraction than commer-
cially available preparations. The aim of the study was to
comparatively analyse the inflammatory effects of different
retraction materials and tetrahydrozoline. Methods. The ef-
fect of retraction liquid on the basis of aluminum chloride
and epinephrine and tetrahydrozoline hydrochloride on gin-
gival tissue of rabbits was investigated. The application time
in the rabbit's gingival sulcus was 7 minutes.  Tissue biopsy
was performed after an hour, a day, and 7 and 30 days. Tis-
sue preparations were analyzed under a microscope. Re-
sults. The obtained results indicate a reversible damage of
gingival tissues as a result of local application of aluminum
chloride- and epinephrine-based retraction agents. Their use
led to acute inflammatory response after an observation pe-
riod of 1 and 7 days. After 30 days reparation of damaged
tissue was observed. The use of tetrahydrozoline resulted in
a visibly weaker inflammatory response. Conclusion. Re-
traction liquids insertion led to an acute inflammatory re-
sponse of gingival tissue which in time assumed a chronic
character. The inflammatory response to the administered
tetrahydrozoline was significantly lower with complete repa-
ration of gingival tissue. Taking this fact into account it is
recommended as a potential retraction agent.
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Apstrakt
Uvod/Cilj. Retrakciona sredstva za privremeno vertikalno i
lateralno povlaÿenje gingivalnog tkiva i kontrolu krvarenja i
protoka teÿnosti u gingivalnom sulkusu trebalo bi da imaju
maksimalnu efikasnost bez ireverzibilnog ošteýenja lokalnog
tkiva i neželjenih sistemskih efekata. U istraživanju se kre-
nulo od pretpostavke da je tetrahidrozolin biološki prihvat-
ljivije sredstvo za gingivalnu retrakciju od komercijalno do-
stupnih preparata. Cilj rada bio je komparativna analiza in-
flamatornog odgovora na dejstvo retrakcionih materijala i
tetrahidrozolina. Metode. Istraživan je efekat retrakcionih
sredstava na bazi aluminijum-hlorida i epinefrina, kao i tet-
rahidrozolin-hidrohlorida na gingivalno tkivo kuniýa. Vreme
primene ispitivanog materijala u gingivalni sulkus kuniýa iz-
nosilo je 7 min. Nakon opservacionog perioda od 1 h, jed-
nog, sedam i 30 dana vršena je biopsija gingivalnog tkiva i
dobijeni preparati su mikroskopski analizirani. Rezultati.
UtvrĀeno je reverzibilno ošteýenje tkiva gingive izazvanog
lokalnom aplikacijom retrakcionih sredstava na bazi alumi-
nijum hlorida i epinefrina. Njihova upotreba, nakon 1-
dnevnog i 7-dnevnog opservacionog perioda, dovela je do
akutnog inflamatornog odgovora. Nakon 30 dana uoÿena je
reparacija ošteýenog tkiva. Primena tetrahidrozolina imala je
za rezultat znaÿajno slabiji inflamatorni odgovor. Zaklju-
ÿak. Upotreba retrakcionih rastvora dovela je do akutnog
inflamatornog odgovora tkiva gingive, koji je vremenom
poprimio hroniÿni karakter. Inflamatorni odgovor sa pri-
menom tetrahidrozolina bio je znaÿajno slabiji sa potpunim
oporavkom gingivalnog tkiva. S obzirom na to tetrahidro-
zolin se može preporuÿiti kao potencijalni retrakcioni agens.
Kljuÿne reÿi:
gingivitis; tkiva; zapaljenje; životinje, laboratorijske.
Introduction
Regular impression taking is a prerequisite for con-
struction of high-quality fixed prosthetic appliance, thus al-
lowing maximum accuracy possible at the contact site of
biological tissue and restoration margin and ensuring integ-
rity of periodontal structures. If a preparation margin is set at
the level of or below the gingival margin, it is necessary to
make it accessible to impression material by reversible tem-
porary shift in apical direction.Volumen 71, Broj 1 VOJNOSANITETSKI PREGLED Strana 47
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One of the most commonly used clinical methods for
gingival retraction is a mechanical-chemical method which
involves the use of special cotton cords of different thick-
ness, impregnated with a solution (retraction agent) 
1. The
role of retraction agent implies temporary vertical and lateral
suppression of gingival tissue as well as bleeding control and
fluid flow in gingival sulcus 
2, 3. For this purpose, vasocon-
strictors (epinephrine) and astringents (aluminum chloride,
aluminum sulfate, zinc chloride) are currently used. The ap-
plied retraction agent is expected to have maximal efficiency
without irreversible damage of local tissue and adverse sys-
temic effects 
4.
On the other hand, some literature findings suggest that
these gingival retraction agents may cause systemic reactions
and local damage to periodontal tissues 
5–7. Systemic effect is
related to epinephrine, especially if it is applied to damaged
marginal gingiva and greater number of teeth, because it is
contraindicated in patients with cardiovascular diseases, hy-
perthyroidism and diabetes 
8, 9. Since astringents act by pre-
cipitation of proteins and show very low cellular permeabil-
ity they cause no systemic effects. Astringents of moderate
concentrations cause irritation of surrounding tissue, and
those of high concentrations cause caustic effect, which is
especially important if one takes into account the fact that
there is inadequate dose control 
4.
Sympathomimetic vasoconstrictors also show retraction
activity and are commercially available as nasal and olfac-
tory decongestives 
7. Thus, these preparations having tetra-
hydrozoline as active component are also advantageous in
dental prosthetics. In this study tetrahydrozoline was as-
sumed to represent biologically more acceptable retraction
agent when compared to commercially available products.
The aim of the study was to compare the effects of dif-
ferent commercially available retraction agents and tetrahy-
drozoline-based preparation on gingival tissue of rabbits.
Methods
The study included 3 commercialy available retraction
agents and tetrahydrozoline-based agent (Table 1).
Experimental studies were carried out in accordance
with the Helsinki Declaration (Approval of the Ethics Com-
mittee of the Faculty of Medicine in Niš, No. 01-2066-2).
The experiment involved 32 experimental male rabbits,
8 weeks of age and 1.8–2.2 kg of weight. The animals were
divided into 4 experimental groups, 8 rabbits for each tested
material. Each animal was administered 10 mg/kg intramus-
cular anesthesia Zoletil
® (Virbac).
Experimental design was based on the following pa-
rameters: investigations were performed on gingival tissue of
all 4 incisors of rabbits from each group; gingiva of the right
incisors in all rabbits were the controls; gingiva of the left
incisors were used for application of tested materials. Appli-
cation was performed in gingival sulcus for 7 min using a
retraction cord (Retracto
®, Roeko) to enable even distribu-
tion of retraction agents. The impregnated cord was carefully
placed along the whole tooth surface using plastic instrument
and dental forceps. Gingival tissue of the upper right incisors
in all the rabbits served as the negative control, ie it was in-
tact tissue in the experiment. Gingival tissue of the lower
right incisor in all the rabbits served as the control of the
false treatment type, representing application of the retrac-
tion cord without tested material in the same way as it was
used in the application of material. Simultaneous gingival
biopsy of the left and right incisors of the jaw was done to
avoid the influence of gingival biopsy injury of adjacent in-
cisor.
The application plan, as well as observation period du-
ration for each of the investigated retraction agents is shown
in Table 2.
After 1 h, 1, 7 and 30 days of the treatment, gingival
tissue samples were taken for histopathological analysis.
Using a scalpel, 2 vertical incisions were made on the labial
gingiva and one horizontal incision at the level of the al-
veolar ridge. Tissue samples of 2 u 2 mm were carefully
separated in vertical direction by a raspatory. Upon biopsy
tissue samples were fixed in 10% formaline. The material
was further dehydrated in increasing concentrations of
ethanol (from 50% to absolute). The material was illumi-
nated by xylene and then put in paraffin molds. Tissue
blocks embedded in periplast were cut on microtome (LKB
Bromma, Sweden) (1.5 μL) and stained by hematoxylin &
eosin (HE) method. Stained preparations were analyzed
histopathologically on a NU-2 microscope (Carl Zeiss,
Germany). The presence of collagen fibers was analyzed
under polarizing light. Intensity of inflammation reaction
was estimated semiquantitatively.
Results
The tissue samples of clinically healthy gingiva of the
negative controls that underwent no surgical procedures
showed normal histological image of the gingiva (Figure 1a).
On histological preparations of the control gingiva of a false
treatment type, 1 h and a day after the treatment mild in-
flammatory reaction was visible (Figure 1b). After 7 and 30
Table 1
Tested materials
Agent Chemical content Manufacturer
Retrargin
® 25% aluminium chloride hexahydrate, pH = 0.8 Galenika, Serbia
Gingiva Liquid
® 10% aluminium chloride hexahydrate, pH = 1.8 Roeko, Italy
Surgident
® retraction solution 8% epinephrine -HCl, pH=2.5 Sigma Dental Systems
Emasdi GmblH, Germany
Visine
® Original 0.05% tetrahydrozoline hydrochloride, pH = 5.6 Pfizer, USAStrana 48 VOJNOSANITETSKI PREGLED Volumen 71, Broj 1
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days from the false treatment examined gingivae were not
histologically different from the negative controls.
The gingival samples treated with different retraction
agents showed different degrees of inflammatory reaction.
One hour after removal of a retraction cord, gingival tissue
showed slight inflammatory changes compared to the con-
trols. All the tissue samples had foci of inflammatory infil-
trate with a reduced amount of collagen fibers (Figure 2).
A day after removal of a retraction cord, inflammatory
infiltration was more prominent in the tissue samples treated
with retraction agents in relation to those treated with tetra-
hydrozoline (Visine
®) (Figure 3).
After a 7 day observation period, the tissue samples
treated with retraction agents showed signs of extensive
acute inflammation. More intense degradation of collagen
fibers was observed after application of epinephrine-based
Table 2
Experimental design of the study
Treatment
Rabitt right incisor
(upper – u; lower - l)
left incisor
(upper – u; lower - l)
Observation period
[hour(s) -  h; day(s) - d]
1st NC(u)
FT (l)
TA (u)
TA (l)
1d
1h
2nd NC(u)
FT (l)
TA (u)
TA (l)
1h
1d
3rd NC(u)
FT (l)
TA (u)
TA (l)
1d
1h
4th NC(u)
FT (l)
TA (u)
TA (l)
1h
1d
5th NC(u)
FT (l)
TA (u)
TA (l)
30d
7d
6th NC(u)
FT (l)
TA (u)
TA (l)
7d
30d
7th NC(u)
FT (l)
TA (u)
TA (l)
30d
7d
8th NC(u)
FT (l)
TA (u)
TA (l)
7d
30d
TA - tested retraction agent; NC -  negative control (intact control); FT – false treatment.
 a)          b)
Fig. 1 – a) The tissue samples of the intact controls (the negative controls) had normal amount of collagen fibres;
b) Negative control preparations after one day biopsy showed mild focal inflammatory infiltrates that were later replaced
with healthy connective tissue (HE, u200).
 a)  b)  c)
Fig. 2 – Histopathological findings after a 1-hour biopsy.
a) Retrargin
® (25% aluminium chloride hexohydrate); b) Surgident
® (8% epinephrine-HCl); c) Visine
® (0.05% tetrohydrozoline
hidrochloride). All tissue samples presented foci of inflammatory infiltrate with reduced amounts of collagen fibres (HE u100).Volumen 71, Broj 1 VOJNOSANITETSKI PREGLED Strana 49
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agent. Tetrahydrozoline-based preparation showed the least
inflammatory effect in this case, where tissue fibrosis was
observed on a histopathological preparation (Figure 4).
With increasing duration of observation period, there
occurred tissue fibrosis, and inflammation became
chronic. The newly formed fibrous tissue was the sign of
defect reparation in the treated tissue. Complete repara-
tion occurred only in case of tetrahydrozoline application
(Figure 5).
Figure 6 shows different amounts of collagen in the tis-
sue structure observed under the polarization microscope af-
ter a 7-day observation period. A small amount of collagen
observed after application of retraction agents was the sign
of more intense acute inflammatory response.
 a)  b)  c)
Fig. 3 – Histopathological findings after a 1-day biopsy (HE, u100).
 a) Retrargin
® (25% aluminium chloride hexahydrate): tissue edema, with focal inflammatory infiltrate, b) Surgident® (8% epinephrine-
HCl): tissue showed strong acute inflammatory response: c) Visine
® (0.05% tetrahydrozoline hidrochloride): there was a mild inflammatory
reaction, but noticeably lower than in the tissue after the removal of retraction cords.
 a)  b)  c)
Fig. 4 – Histopathological findings after a 7-day biopsy (HE, u100).
a) Gingival liquid: tissue samples after the removal of retraction cords with aluminum chloride showed signs of extensive inflammatory
reactions; b) Surgident
® (8% epinephrine-HCl): inflammatory response and the reduced amount of collagen fibers of small-scale than that
presented in Fig. – 4a); c) Visine® (0.05% tetrahydrozoline hidrochloride): tissue fibrosis.
 a)  b)  c)
Fig. 5 – Histopathological findings after a 1-month biopsy (HE, u100).
a) Retrargin
® (25% aluminium chloride hexahydrate) and b) Surgident
® (8% epinephrine-HCl): tissue preparations showed a reduced
amount of collagen fibers and less focal inflammatory infiltrates, c) Visine
® (0.05% tetrahydrozoline hidrochloride): a month after the
removal of  terahydrozoline, there was complete reparation of gingival tissue.
 a)  b)  c)
Fig. 6 – Amount of collagen fibers in the gingival tissue 7 days after the application of retraction agents (magnification u100).
 a) normal amount of collagen in the negative controls; b) reduced amount of collagen in the gingival tissue treated with Retrargin® (25% aluminium
chloride hexahydrate); c)  reduced amound of collagen in the gingival tissue treated with Visine
® (0.05% tetrahydrozoline hidrochloride).Strana 50 VOJNOSANITETSKI PREGLED Volumen 71, Broj 1
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Discussion
In order to make an adequate impression of the mar-
ginal line area located in or below the gingival level it is nec-
essary to dilate and dry the gingival sulcus. The consequent
ischaemia is reversible and is accompanied by reactive hy-
peremia limited to a 17-minute period upon cord removal 
8.
Prolonged ischaemia might lead to tissue damage and necro-
sis. Changes that occur after retraction procedure usually last
from 1 to 2 weeks 
10. Still, infection or serious tissue damage
may develop within this period 
5. Changes occur at the junc-
tion line of gingiva and connective tissue and may result in
periodontitis, apical migration of epithelial junction and al-
teration of cement surface. After a period of tissue reparation
clinically acceptable apical migration of marginal gingiva
must not exceed 0.1 mm  
4, 11.
Jokstad 
12 has shown that the retraction effect of epi-
nephrine- and aluminum-salt-based astringents is almost
equal. On the other hand, there is a wide range of adverse
systemic reactions to absorption of epinephrine, which sig-
nificantly reduces its indication area. Therapeutic effect of
epinephrine is vasoconstriction of blood vessels, leading to
increased blood pressure and heart rate. The risk increases
if epinephrine in retraction agent is combined with local
anaesthetic, endogenous secretion in a stressful situation, or
at greater damage of gingival tissue during tooth prepara-
tion 
13. In this study, retraction agents were administered to
healthy gingival sulci, without previous tooth preparation,
so as not to damage the tissue during preparation and thus
jeopardize the objectivity of the results. Retraction was the
result of local absorption of a retraction agent and the de-
gree of resorption depended on the degree of tissue damage
as well 
14.
Previous studies have shown that retraction agents
damage epithelium, sulcus epithelium as well as connective
tissue in vitro and in vivo conditions 
6, 15. Changes in the
periodontal tissue may be the result of mechanical damage
of epithelium during application of retraction cord, but are
more often related to the effect of the applied retraction
agent. From the clinical point of view, the use of retraction
cord without retraction agent indicates lower therapeutic ef-
fect 
11.
The obtained results show that careful application of
retraction cord cause no inflammatory changes in gingival
tissue. The study results indicate a reversible damage to gin-
gival tissue as a result of local application of aluminum-
chloride- and epinephrine-based retraction agents. There
were no significant changes in tissue structure 1 h after re-
traction agents removal. However, their use led to acute in-
flammatory response after an observation period of one and
seven days. After thirty days reparation of damaged tissue
was observed. These results are consistent with the findings
of Harrison 
16 and Ramadan et al. 
17.
Tetrahydrozoline belongs to the group of sympathomi-
metic vasoconstrictors or Į-adrenergic agonists and is com-
mercially available as nasal and olfactory decongestants.
Systemic reactions to the use of these products are very rare,
given that the maximum recommended doses are signifi-
cantly higher than those required for effective gingival re-
traction 
2. Studies by Bowles et al. 
2 showed a satisfactory
clinical effect of tetrahydrozoline, strong local vasoconstric-
tive effect and absence of systemic reactions. Clinical study
conducted by Tardy et al. 
18 demonstrated greater retraction
efficiency of tetrahydrozoline in relation to epinephrine
without adverse effects.
An in vitro study by Kopaþ et al. 
19, 20 found signifi-
cantly lower damage of cell cultures treated by tetrahydrozo-
line compared to aluminum chloride. Retraction agents rep-
resent acidic solutions with pH values from 0.8 to 3, the pa-
rameter which is considered to be major cause of periodontal
tissue damage 
21. Conversely, pH value of tetrahydrozoline is
5.6, so it is considered biologically acceptable from that
point of view 
20. An in vitro study of Nowakowska et al. 
22
showed high cell viability values of human gingival fibro-
blasts after treatment with tetrahydrozoline-HCl based gels.
On the other hand, the authors demonstrated cytotoxic activ-
ity of astringent retraction agents 
23.
Inflammatory changes occurred as the result of applica-
tion of tetrahydrozoline were of significantly lower intensity
compared to the retraction agents based on aluminum chlo-
ride and epinephrine, and resulted in a complete tissue repa-
ration after a 1-month observation period. Tetrahydrozoline
proved to be biologically acceptable in relation to the inves-
tigated retraction agents. As biocompatibility is considered to
be an essential feature of dental materials, clinical use of
terahydrozoline is recommended 
24.
Conclusion
All the examined retraction agents led to an acute in-
flammatory infiltration of gingival tissue in rabbits, which
eventually became chronic. The inflammatory response to
the administered tetrahydrozoline was significantly lower
with complete reparation of tissue. Taking this fact into ac-
count it is recommended as a potential retraction agent.
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